Importance of the Test
- Identifying patients eligible for targeted TRK inhibitor therapies.
- Providing treatment options for advanced or metastatic solid tumors.
- Improving the accuracy of genetic cancer diagnosis.
A sophisticated genetic test identifying rare NTRK fusions that drive tumor growth. This allows oncologists to select precise targeted therapies that treat the genetic cause regardless of the primary cancer location.
Scientific name: NTRK Gene Fusion Comprehensive Testing
A comprehensive molecular analysis detecting NTRK gene fusions in tumor cells. This test serves as a critical biomarker to identify patients eligible for modern TRK inhibitor therapies, offering personalized treatment options.